Navigation Links
Aflac Honored with Corporate Citizenship Award

U.S. Chamber of Commerce awards Aflac and the Aflac Cancer Center for

partnering in the fight against pediatric cancer.

COLUMBUS, Ga., Nov. 8 /PRNewswire/ -- Last night, the relationship that started over ten years ago between Aflac and the Aflac Cancer Center and Blood Disorders Service at Children's Healthcare of Atlanta was honored with a U.S. Chamber of Commerce's Corporate Citizenship Award. During a prestigious ceremony hosted by television personality, Ed McMahon in Washington, D.C., Aflac and the Aflac Cancer Center took home the award in the partnership category for their efforts supporting pediatric cancer research and treatment.

The Partnership Award recognizes a company and a charitable organization that have exemplified cooperative success in addressing an important social issue. Organized by the Business Civic Leadership Center (BCLC), the partnership prize is a people's choice award determined by a public online vote. Nearly 24,000 voters cast ballots between September 6 and October 5 selecting Aflac and the Aflac Cancer Center as winners in this category.

"We are especially proud to be recognized for our long-standing relationship with The Aflac Cancer Center," said Dan Amos, Aflac's Chairman and CEO. "We are grateful to everyone who voted for us in the partnership category and hope they too will be inspired to support this worthy cause."

In researching companies for the award, the BCLC in conjunction with the U.S. Chamber of Commerce reviewed over 125 written nominations to select five finalists. Online voters then selected the winner from the top-five nominees.

"Business-nonprofit partnerships are a significant force for good in the U.S.," said BCLC Executive Director Stephen Jordan. "Aflac's commitment to Children's Healthcare of Atlanta is inspiring, and this is our way of thanking both organizations for the difference they make in the lives of our nation's children and calling attention to their important work."

Since 1995, Aflac along with its employees and sales associates have contributed over $36 million to the Aflac Cancer Center.

"The partnership between Aflac and the Aflac Cancer Center is unparalleled. Aflac's desire to realize a cure for childhood cancer and blood disorders is as strong as that of our researchers, clinicians and patient families. This desire is embraced by their employees and sales force. Aflac is a true champion for childhood cancer and blood disorders," stated Diane Vaughn, Senior Development Officer for Children's Healthcare of Atlanta.

The BCLC's Corporate Citizenship Awards showcases a total of six businesses, trade associations, chambers of commerce and partner organizations for demonstrating ethical leadership and corporate stewardship and for making a positive difference in society. In addition to the Partnership Award, the International Community Service Award, the U.S. Community Service Award and the Corporate Stewardship Award for Small, Midsize and Large Business, were presented during the gala.

About Aflac

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven consecutive years and in Fortune magazine's list of the 100 Best Companies to Work For in America for nine consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac, visit

About the Aflac Cancer Center and Blood Disorders Services of Children's Healthcare of Atlanta

The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving infants to young adults. Recognized as one of the top five pediatric cancer centers in the country by Child magazine, the Aflac Cancer Center treats more than 325 new cancer patients each year and follows more than 2,000 patients with sickle cell disease, hemophilia and other blood disorders. The Aflac Cancer Center is one of many programs at Children's committed to enhancing the lives of children through excellence in patient care, research and education. Children's, one of the top three pediatric healthcare systems in the country, is a not-for-profit organization that benefits from the generous philanthropic and volunteer support of our community. Visit or call 404-250-KIDS for more information.


Media Contacts:

Mechell Clark Yolonda King

Aflac Incorporated Aflac Incorporated

(706) 243-8004 Voice (706) 243-8547 Voice

(706) 320-2288 Fax (706) 320-2288 Fax

Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Vical Names Andrew de Guttadauro Vice President, Corporate Development
5. Signalife Provides Corporate Update
6. Biomira Announces Plan to Reincorporate in the United States
7. Pressure BioSciences, Inc. Provides Corporate Update
8. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
9. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
10. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
11. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential micronutrient ... to proteins, copper is also toxic to cells. With a $1.3 million award ... will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):